Evidence map›Paper›PMID 33881905›Full record

ArticleJCO oncology practice2021

Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy.

Heidi D Klepin, Can-Lan Sun, David D Smith, Rawad Elias, Kelly M Trevino, Ashley Leak Bryant, Daneng Li, Christian Nelson, William P Tew, Supriya G Mohile and 10 more

Open access · greenAbstract read
In one paragraph

Article in JCO oncology practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effect of polypharmacy and potentially inappropriate medications on physical functional decline among older adults with advanced cancer receiving systemic treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  4. Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic Toxicity in Older Adults With Advanced Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Trial
  5. Trial
  6. Potentially preventable unplanned hospitalizations due to adverse events in patients receiving systemic anticancer therapy: a retrospective single-center study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cumulative frailty impact on unplanned hospitalization in older patients with cancer and excellent Eastern Cooperative Oncology Group performance.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Addressing Disability in Cancer Survivors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  17. Spatiotemporal Patterns of Hospitalizations Among Older Adults With Co-Presence of Cancer and Dementia in US Counties: 2013-2018.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2024
    Article
  18. Article
  19. How old is too old? Frailty and geriatric assessments of older patients undergoing allogeneic HCT.Hematology. American Society of Hematology. Education Program · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 1 country.

Heidi D KlepinWake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC.ORCID 0000-0002-6262-1123
Can-Lan SunCity of Hope Comprehensive Cancer Center, Duarte, CA.
David D SmithCity of Hope Comprehensive Cancer Center, Duarte, CA.
Rawad EliasHartford Healthcare Cancer Institute, Hartford, CT.
Kelly M TrevinoMemorial Sloan Kettering Cancer Center, New York City, NY.
Ashley Leak BryantLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Daneng LiCity of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0001-5330-7522
Christian NelsonMemorial Sloan Kettering Cancer Center, New York City, NY.
William P TewMemorial Sloan Kettering Cancer Center, New York City, NY.
Supriya G MohileUniversity of Rochester Medical Center, Rochester, NY.
Ajeet GajraCardinal Health, Dublin, OH.ORCID 0000-0002-5929-0466
Cynthia OwusuCase Western University School of Medicine, Cleveland, OH.
Cary GrossCancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT.
Stuart M LichtmanMemorial Sloan Kettering Cancer Center, New York City, NY.ORCID 0000-0003-4146-6192
Vani V KatheriaCity of Hope Comprehensive Cancer Center, Duarte, CA.
Hyman B MussLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Andrew E ChapmanSidney Kimmel Cancer Center/Jefferson Health, Philadelphia, PA.ORCID 0000-0001-6040-8612
Harvey Jay CohenDuke University, Durham, NC.
Arti HurriaCity of Hope Comprehensive Cancer Center, Duarte, CA.
William DaleCity of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0001-8674-9394
City of Hope · USMemorial Sloan Kettering Cancer Center · USUniversity of North Carolina at Chapel Hill · USAtrium Health Wake Forest Baptist · USCardinal Health (United States) · USDuke University · USHartford Hospital · USThomas Jefferson University Hospital · USUniversity of Rochester Medical Center · USUniversity School · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Pilot CoreP30AG022845 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Manney Carrington Reid · 2003 to 2026
$15.2M
Geriatric Oncology Research Infrastructure to Improve Clinical CareR33AG059206 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE, Heidi Diana Klepin · 2020 to 2026
$5.1M
A Patient-Oriented Research Program in Geriatric OncologyK24AG056589 · NIA · UNIVERSITY OF ROCHESTER · PI Supriya G. Mohile · 2018 to 2026
$1.5M
Mentoring the Next Generation of Geriatric Oncology Researchers in Patient-Oriented Research to Improve the Care of Older Adults with CancerK24AG055693 · NIA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WILLIAM DALE · 2018 to 2026
$1.4M
Can Geriatric Assessment Predict Oncology Outcomes?K23AG026749 · NIA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI HURRIA, ARTI · 2005 to 2009
$874k
Minimizing Physical Function Decline in Older Adults Receiving ChemotherapyK23AG038361 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KLEPIN, HEIDI DIANA · 2011 to 2014
$562k
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA008748NCI NIH HHS UG1 CA189961NIA NIH HHS K23 AG026749NIA NIH HHS K23 AG038361NIA NIH HHS K24 AG055693NIA NIH HHS K24 AG056589NIA NIH HHS P30 AG022845NIA NIH HHS R33 AG059206
6 · The paper itself

Abstract

purposeHospitalizations during cancer treatment are costly, can impair quality of life, and negatively affect therapy completion. Our objective was to identify risk factors for unplanned hospitalization among older adults receiving chemotherapy.

methodsThis is a secondary analysis of a multisite cohort study (N = 750) of patients ≥ 65 years of age evaluated with a geriatric assessment (GA) to predict chemotherapy toxicity. The primary outcome of this analysis was unplanned hospitalizations during treatment; the secondary outcome was length of stay (LOS) of the first hospitalization. Independent variables included pretreatment GA measures, laboratory values, cancer type and stage, and treatment intensity characteristics. We used logistic regression to estimate the odds of hospitalization and generalized linear models for LOS in multivariable analyses.

resultsThe sample median age was 72 years (range, 65-94 years); 59% had stage IV disease. At least one unplanned hospitalization occurred in 193 patients (25.7%) during receipt of chemotherapy. In multivariable analyses controlling for cancer type, the following baseline characteristics were significantly associated with increased odds of hospitalization: needing help bathing or dressing (odds ratio [OR], 1.8; 95% CI, 1.0 to 3.1), polypharmacy (≥ 5 meds) (OR, 1.6; 95% CI, 1.1 to 2.4), more comorbid conditions (OR, 1.1; 95% CI, 1.0 to 1.3), availability of someone to take them to the doctor (OR, 2.0; 95% CI, 1.0 to 4.1), CrCl < 60 mL/min (OR, 1.7; 95% CI, 1.1 to 2.4), and albumin < 3.5 g/dL (OR, 1.8; 95% CI, 1.2 to 2.8). In multivariable analyses, older age, self-reported presence of liver or kidney disease, living alone and depressive symptoms were associated with longer LOS.

conclusionReadily available GA variables and laboratory data, but not age, were associated with unplanned hospitalizations among older adults receiving chemotherapy. If validated, these data can inform prediction models and the design of interventions to decrease unplanned hospitalizations.

Indexed as

NeoplasmsQuality of LifeAgedCohort StudiesGeriatric AssessmentHospitalizationHumansLength of Stay

Identifiers

PMID33881905
PMCPMC8258152
OpenAlexW3152960051

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.